Workflow
亚虹医药: 江苏亚虹医药科技股份有限公司第二届监事会第十四次会议决议公告

Meeting Overview - The second meeting of the Supervisory Board of Jiangsu Yahon Pharmaceutical Technology Co., Ltd. was held on August 28, 2025, with full attendance of all three supervisors [1][2] - The meeting was convened in accordance with the relevant laws and regulations, ensuring the legality and validity of the resolutions made [1] Resolutions Passed - The Supervisory Board approved the company's 2025 semi-annual report and its summary, confirming that the report accurately reflects the company's actual situation without any false records or omissions [1][2] - The board also approved the special report on the storage and actual use of raised funds for the first half of 2025, with unanimous support [2] - A significant resolution was passed to cancel the Supervisory Board, transferring its powers to the Audit Committee of the Board of Directors, and to amend the company's articles of association accordingly [2][3] - The resolution regarding the change in registered capital and the necessary business registration changes was also approved, pending submission to the shareholders' meeting for further deliberation [3]